Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy

Jia-Neng Tan, Sabrina Haroon, Amartya Mukhopadhyay, Titus Lau, Tanusya Murali Murali, Jason Phua, Zong-Yao Tan, Nicholas Lee, Horng‐Ruey ChuaJournal of Intensive Care Medicine 2017 · DOI

Abstract

Hyperlactatemia predicts CI during RCA-CVVH with reasonable discriminatory performance in critically ill patients. Serum lactate surveillance may help preempt issues with citrate toxicity.
BibTeX
@article{tan2017hyperlactatemia,
  author = {Jia-Neng Tan and Sabrina Haroon and Amartya Mukhopadhyay and Titus Lau and Tanusya Murali Murali and Jason Phua and Zong-Yao Tan and Nicholas Lee and Horng‐Ruey Chua},
  title = {{Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy}},
  journal = {Journal of Intensive Care Medicine},
  year = {2017},
  doi = {10.1177/0885066617701068},
}

Loading related content...

Figure